FDA
-
-
-
-
-
-
-
Viatris to present contraceptive patch data at ACOG meeting
-
-
-
-
-
-
-
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
-
-
-
-
-
-
-
Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection
-
-
-
-
-
-
-
Goldman Sachs Starts Viatris (VTRS) at Neutral
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
-
-
-
-
-
-
VTRS DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Acti
-
328,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

